SCHEMBL23547437

SCHEMBL23547437

C[C@H]1CCN(C(=O)/C=C/CN(C)C)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 4/20 0.43
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 2/20 0.42
HPGD P15428 2/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
BTK Q06187 4/20 0.41
EGFR P00533 1/20 0.39
FGFR2 P21802 4/20 0.38
FGFR1 P11362 1/20 0.38
FGFR4 P22455 1/20 0.38
FGFR3 P22607 1/20 0.38
LMNA P02545 2/20 0.38
CDK4 P11802 1/20 0.37
CDK7 P50613 1/20 0.37
CDK9 P50750 1/20 0.37
GAA P10253 1/20 0.37
KDR P35968 1/20 0.36
LCK P06239 1/20 0.36
CDK14 O94921 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18909618 1.00 JAK3 (0.43) JAK3ALDH1A1NPC1HPGDRAB9A
SCHEMBL27451749 1.00 JAK3 (0.43) JAK3ALDH1A1NPC1HPGDRAB9A
SCHEMBL18904853 1.00 JAK3 (0.43) JAK3ALDH1A1NPC1HPGDRAB9A
SCHEMBL19353252 0.92 ALDH1A1 (0.51) JAK3ALDH1A1NPC1HPGDRAB9A
SCHEMBL10241495 0.92 ALDH1A1 (0.51) JAK3ALDH1A1NPC1HPGDRAB9A
SCHEMBL10283866 0.92 ALDH1A1 (0.51) JAK3ALDH1A1NPC1HPGDRAB9A
SCHEMBL27451704 0.92 ALDH1A1 (0.51) JAK3ALDH1A1NPC1HPGDRAB9A
SCHEMBL24348777 0.91 ALDH1A1 (0.47) JAK3ALDH1A1NPC1HPGDRAB9A
SCHEMBL462207 0.90 ALDH1A1 (0.44) JAK3ALDH1A1NPC1HPGDBTK
SCHEMBL18909668 0.88 CHRNB2 (0.38) JAK3ALDH1A1HPGDBTKEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021121390-A1 HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF AND APPLICATION THEREOF 苏州信诺维医药科技股份有限公司 2021-06-24 WO disclosed